UY34758A - USO INTRAUTERINO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA. - Google Patents
USO INTRAUTERINO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA.Info
- Publication number
- UY34758A UY34758A UY0001034758A UY34758A UY34758A UY 34758 A UY34758 A UY 34758A UY 0001034758 A UY0001034758 A UY 0001034758A UY 34758 A UY34758 A UY 34758A UY 34758 A UY34758 A UY 34758A
- Authority
- UY
- Uruguay
- Prior art keywords
- beta
- metilen
- espirox
- onas
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Abstract
La presente invención describe el uso intrauterino de 18?metil?15ß,16ß?metilen? 19?nor?20?espirox?4?en?3?onas de la fórmula general (1) en la anticoncepción la terapia ginecológica, así como un sistema intrauterino que contiene compuestos de la fórmula 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012206652 | 2012-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34758A true UY34758A (es) | 2013-11-29 |
Family
ID=48142002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034758A UY34758A (es) | 2012-04-23 | 2013-04-23 | USO INTRAUTERINO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA. |
Country Status (28)
Country | Link |
---|---|
US (1) | US20150065472A1 (es) |
EP (1) | EP2841074A1 (es) |
JP (1) | JP2015514791A (es) |
KR (1) | KR20150004807A (es) |
CN (1) | CN104254333A (es) |
AR (1) | AR090799A1 (es) |
AU (1) | AU2013254840A1 (es) |
BR (1) | BR112014026193A2 (es) |
CA (1) | CA2871003A1 (es) |
CL (1) | CL2014002836A1 (es) |
CO (1) | CO7111255A2 (es) |
CR (1) | CR20140490A (es) |
CU (1) | CU20140121A7 (es) |
DO (1) | DOP2014000241A (es) |
EA (1) | EA201491922A1 (es) |
EC (1) | ECSP14024250A (es) |
HK (1) | HK1205000A1 (es) |
IL (1) | IL235095A0 (es) |
IN (1) | IN2014DN07839A (es) |
MA (1) | MA37444A1 (es) |
MX (1) | MX2014012849A (es) |
PE (1) | PE20142438A1 (es) |
PH (1) | PH12014502372A1 (es) |
SG (1) | SG11201406582XA (es) |
TN (1) | TN2014000444A1 (es) |
TW (1) | TW201350122A (es) |
UY (1) | UY34758A (es) |
WO (1) | WO2013160213A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015055789A1 (en) * | 2013-10-17 | 2015-04-23 | Bayer Pharma Aktiengesellschaft | INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH30867A (en) | 1992-07-31 | 1997-12-09 | Leiras Oy | Method and equipment for installing a medicine capsule on a support. |
FI90627C (fi) | 1992-07-31 | 1994-03-10 | Leiras Oy | Laitteisto lääkeainesauvan varustamiseksi vaipalla |
FI107339B (fi) | 1998-06-30 | 2001-07-13 | Leiras Oy | Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi |
US6056976A (en) | 1998-11-12 | 2000-05-02 | Leiras Oy | Elastomer, its preparation and use |
WO2001052857A1 (en) * | 2000-01-18 | 2001-07-26 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
CN101001631B (zh) * | 2003-07-16 | 2014-08-06 | 特卫华妇女健康有限公司 | 利用连续给予雌激素的避孕方案的激素治疗方法 |
DE102006030416A1 (de) * | 2006-06-29 | 2008-01-03 | Bayer Schering Pharma Ag | 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate |
DE102007011105A1 (de) * | 2007-03-02 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose |
DE102007063495A1 (de) * | 2007-12-29 | 2009-09-17 | Bayer Schering Pharma Aktiengesellschaft | 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel |
DE102007063496A1 (de) * | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
EP2140860A1 (en) * | 2008-07-03 | 2010-01-06 | Bayer Schering Pharma Oy | An improved method of contraception |
HU230345B1 (hu) * | 2010-11-08 | 2016-02-29 | Hll Lifecare Limited | Méhbe helyezhető eszköz szabályozott rézleadással |
-
2013
- 2013-04-11 TW TW102112904A patent/TW201350122A/zh unknown
- 2013-04-19 EA EA201491922A patent/EA201491922A1/ru unknown
- 2013-04-19 SG SG11201406582XA patent/SG11201406582XA/en unknown
- 2013-04-19 MX MX2014012849A patent/MX2014012849A/es unknown
- 2013-04-19 AU AU2013254840A patent/AU2013254840A1/en not_active Abandoned
- 2013-04-19 BR BR112014026193A patent/BR112014026193A2/pt not_active Application Discontinuation
- 2013-04-19 IN IN7839DEN2014 patent/IN2014DN07839A/en unknown
- 2013-04-19 CN CN201380021453.6A patent/CN104254333A/zh active Pending
- 2013-04-19 CA CA2871003A patent/CA2871003A1/en not_active Abandoned
- 2013-04-19 JP JP2015507482A patent/JP2015514791A/ja active Pending
- 2013-04-19 US US14/396,736 patent/US20150065472A1/en not_active Abandoned
- 2013-04-19 PE PE2014001786A patent/PE20142438A1/es not_active Application Discontinuation
- 2013-04-19 EP EP13717289.6A patent/EP2841074A1/de not_active Withdrawn
- 2013-04-19 WO PCT/EP2013/058220 patent/WO2013160213A1/de active Application Filing
- 2013-04-19 KR KR1020147029292A patent/KR20150004807A/ko not_active Application Discontinuation
- 2013-04-23 UY UY0001034758A patent/UY34758A/es not_active Application Discontinuation
- 2013-04-23 AR ARP130101341A patent/AR090799A1/es unknown
-
2014
- 2014-10-19 IL IL235095A patent/IL235095A0/en unknown
- 2014-10-21 MA MA37444A patent/MA37444A1/fr unknown
- 2014-10-21 CL CL2014002836A patent/CL2014002836A1/es unknown
- 2014-10-22 PH PH12014502372A patent/PH12014502372A1/en unknown
- 2014-10-22 TN TN2014000444A patent/TN2014000444A1/fr unknown
- 2014-10-23 CR CR20140490A patent/CR20140490A/es unknown
- 2014-10-23 CO CO14235159A patent/CO7111255A2/es unknown
- 2014-10-23 CU CU2014000121A patent/CU20140121A7/es unknown
- 2014-10-23 DO DO2014000241A patent/DOP2014000241A/es unknown
- 2014-10-24 EC ECIEPI201424250A patent/ECSP14024250A/es unknown
-
2015
- 2015-06-24 HK HK15105985.9A patent/HK1205000A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IN2014DN07839A (es) | 2015-04-24 |
TN2014000444A1 (en) | 2016-03-30 |
HK1205000A1 (en) | 2015-12-11 |
JP2015514791A (ja) | 2015-05-21 |
CA2871003A1 (en) | 2013-10-31 |
MA37444A1 (fr) | 2016-11-30 |
TW201350122A (zh) | 2013-12-16 |
AR090799A1 (es) | 2014-12-10 |
CL2014002836A1 (es) | 2015-03-13 |
MX2014012849A (es) | 2015-02-05 |
BR112014026193A2 (pt) | 2017-06-27 |
WO2013160213A1 (de) | 2013-10-31 |
PE20142438A1 (es) | 2015-02-01 |
PH12014502372A1 (en) | 2015-01-26 |
DOP2014000241A (es) | 2014-12-31 |
KR20150004807A (ko) | 2015-01-13 |
CN104254333A (zh) | 2014-12-31 |
US20150065472A1 (en) | 2015-03-05 |
CU20140121A7 (es) | 2014-12-26 |
ECSP14024250A (es) | 2015-12-31 |
SG11201406582XA (en) | 2014-11-27 |
EA201491922A1 (ru) | 2015-04-30 |
EP2841074A1 (de) | 2015-03-04 |
IL235095A0 (en) | 2014-12-31 |
AU2013254840A1 (en) | 2014-11-06 |
CR20140490A (es) | 2014-11-17 |
CO7111255A2 (es) | 2014-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2017000078A (es) | Indazoles sustituidos con bencilo como inhibidores de bub1. | |
UY34566A (es) | 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
UY34585A (es) | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso | |
UY35500A (es) | Indazoles sustituidos con heteroarilo | |
UY34797A (es) | Uracilos sustituidos bicíclicamente y uso de los mismos | |
UY34632A (es) | Compuestos de oxazolidin- 2- ona y usos de los mismos | |
CL2016000807A1 (es) | Amino heteroarilo benzamidas como inhibidores de quinasa. | |
UY34605A (es) | Derivados de arilalquiloxipirimidina e insecticidas agrohortícolas que comprenden dichos derivados como principios activos, y método de uso de los mismos | |
CL2015001985A1 (es) | Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim. | |
UY34220A (es) | Indazoles, composiciones farmacéuticas y uso de los mismos | |
UY34539A (es) | Heteroarilos y usos de los mismos | |
UY34610A (es) | Pirroldicarboxamidas condensadas y su uso como agentes farmacéuticos. | |
UY34541A (es) | ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?. | |
UY34200A (es) | 3-(fluorovinil)pirazoles y su uso | |
UY35499A (es) | Indazoles sustituidos con diaminoheteroarilo | |
UY34767A (es) | Inhibidores cíclicos del enlace éter de dgat1 | |
UY36737A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
UY34590A (es) | Fenilimidazopirazoles sustituidos y su uso | |
UY34761A (es) | Composiciones parasiticidas que comprenden derivados de benzimidazol, métodos y usos de los mismos. | |
DOP2016000021A (es) | Imidazotiazol sulfonamidas como nematicidas | |
UY34082A (es) | Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona,preparación de los mismos y uso terapéutico de los mismos | |
UY34543A (es) | Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica. | |
UY34758A (es) | USO INTRAUTERINO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA. | |
UY34646A (es) | Compuestos de espirohidantoína y su uso como moduladores selectivos del receptor de andrógenos | |
UY34564A (es) | Utilización en terapéutica de derivados de imidazopiridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20210526 |